Biotech grants

Scheduled

Funds a €3M coordination action that benchmarks emerging industrial bio-based systems for cleaner, circular and more competitive European value chains.

Scheduled

Funds three €4M research projects that replace hazardous biocidal actives with safer bio-based substances for wood and mosquito control.

Scheduled

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

Scheduled

Funds two €7–8M innovation projects that move food-system microbiome products from validated testing toward reliable EU-market scale-up.

Scheduled

Funds two projects to use livestock microbiomes for healthier animals, lower antimicrobial use and safer, more sustainable One Health systems.

Scheduled

Funds a center of excellence built around one chosen theme in helping older adults stay independent.

Scheduled

Funds multicenter clinical trials, with mechanism studies, testing ways to improve outcomes across heart, lung, kidney, liver and gut transplants.

Scheduled

Funds specialised centers running basic, translational and clinical muscular dystrophy research together, with patients built into the design.

Scheduled

Funds an established investigator's whole direction of research inside one NIH institute, instead of a single defined project.

Scheduled

Funds mapping how nutrients, drugs and chemicals cross the placenta, gut, mammary gland and blood-brain barrier in pregnancy and infancy.

Scheduled

Funds research using ancient human DNA data to understand the diseases and traits people carry today.

Scheduled

Supports collaboration between Walloon universities and firms through a regional innovation grant for joint development.

Between cycles

Funds a specialised, multi-investigator centre on alcohol misuse and its consequences, built to outperform its individual research projects added up.

Between cycles

Funds the continued operation and improvement of an already-established biomedical data repository or knowledgebase with a track record of impact.

Between cycles

Funds a collaborative framework — Chair's Grant, Coordinating Center and Resource Centers — for complex, multi-site clinical vision research.

Between cycles

Funds a core center that pools already-funded substance-use, addiction and HIV investigators into one transformative research program.

Between cycles

Funds a multidisciplinary research programme of at least two linked projects and an administrative core, built around one shared scientific theme.

Between cycles

Funds an early-career investigator's own research into the chronic conditions, coinfections and comorbidities that complicate long-term HIV.

Between cycles

Funds one clinical research network — a single $15 million award — running trials on new antibiotics, better use of old ones, and diagnostics.

Between cycles

Funds the single hub that coordinates communication across labs in NIDCD's national ear-tissue research network.

Between cycles

Funds a laboratory that procures and distributes human ear tissue to researchers studying hearing and balance disorders.

Between cycles

Invests research teams and institutions for EB Research Project Grants in biotechnology, medical technology, and synthetic biology.

Between cycles

Funds developing an assay and screening to identify a therapeutic agent, ahead of characterisation and efficacy testing on it.

Between cycles

Funds pharmacodynamic, pharmacokinetic and efficacy testing that shows a therapeutic agent has enough biological activity to justify further development.